A Phase II Study of Memantine in the Treatment of Recurrent Glioblastoma.

Trial Profile

A Phase II Study of Memantine in the Treatment of Recurrent Glioblastoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 11 Dec 2015

At a glance

  • Drugs Memantine (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2013 Planned End Date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
    • 11 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 16 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top